不妊検査デバイスの世界市場：2022-2028年

世界の不妊検査デバイスの市場規模は予測期間中に5.9%のCAGRで大幅な成長を示すと予測されています。

女性の出生率の低下や、オンラインウェブサイトやポータルサイトでのデバイスやキットのアベイラビリティが市場の主要な推進要因となっています。また、技術の進歩、肥満の有病率の上昇、女性の初回妊娠の中央値の上昇も予測期間中の市場成長を促進する要因となっています。さらに、ポイントオブケアデバイスの採用や卵巣疾患の有病率の上昇も同市場の成長を促進する主な要因となっています。

当レポートでは、世界の不妊検査デバイスの市場を調査し、市場概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 レポートの概要

第2章 市場概要・洞察

第3章 競合情勢

• 主要企業分析
• 主要戦略分析

第4章 市場決定要因

• 推進要因
• 抑制要因
• 機会

第5章 市場分析：区分別

• 世界の不妊検査デバイス市場：タイプ別
  • 女性不妊検査
  • 男性不妊検査
• 世界の不妊検査デバイス市場：規制分類別
  • OTC
  • 処方箋（Rx）
• 世界の不妊検査デバイス市場：エンドユーザー別
  • 病院・不妊治療クリニック
  • 在宅ケア

第6章 地域分析

• 北米
• 欧州
• アジア太平洋
• その他の地域

第7章 企業プロファイル

• Abbott Laboratories, Inc.
• Alfa Scientific Designs, Inc.
• Ava Science Inc.
• Babystart Ltd.
• bioMerieux S.A
• bioZhena Corp.
• Church & Dwight Co, Inc.
• Cook Medical Inc.
• Eli Lilly And Co.
• Fairhaven Health, LLC
• Fertility Focus Ltd.
• Gemc Technology Group Ltd.
• Geratherm Medical AG
• GlaxoSmithKline plc
• Hilin Life Products, Inc.
• Janssen Global Services, LLC
• Merck KGaA
• Novartis International AG
• Pfizer Inc.
• SPD Swiss Precision Diagnostics GmbH
• TaiDoc Technology Corp

LIST OF TABLES

• 1. GLOBAL FERTILITY TESTING DEVICES MARKET RESEARCH AND ANALYSIS BY TYPE,2020-2027 ($ MILLION)
• 2. GLOBAL FEMALE FERTILITY TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 3. GLOBAL FEMALE FERTILITY TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
• 4. GLOBAL MALE FERTILITY TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 5. GLOBAL FERTILITY TESTING DEVICES MARKET RESEARCH AND ANALYSIS BY REGULATORY CLASSIFICATION, 2020-2027 ($ MILLION)
• 6. GLOBAL OVER THE COUNTER (OTC) MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 7. GLOBAL PRESCRIPTION (Rx) MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 8. GLOBAL FERTILITY TESTING DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
• 9. GLOBAL HOSPITALS AND FERTILITY CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 10. GLOBAL HOME CARE SETTING MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 11. NORTH AMERICAN FERTILITY TESTING DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
• 12. NORTH AMERICAN FERTILITY TESTING DEVICES MARKET RESEARCH AND ANALYSIS BY TYPE,2020-2027 ($ MILLION)
• 13. NORTH AMERICAN FERTILITY TESTING DEVICES MARKET RESEARCH AND ANALYSIS BY REGULATORY CLASSIFICATION,2020-2027 ($ MILLION)
• 14. NORTH AMERICAN FERTILITY TESTING DEVICES MARKET RESEARCH AND ANALYSIS BY END USER, 2020-2027 ($ MILLION)
• 15. EUROPEAN FERTILITY TESTING DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
• 16. EUROPEAN FERTILITY TESTING DEVICES MARKET RESEARCH AND ANALYSIS BY TYPE,2020-2027 ($ MILLION)
• 17. EUROPEAN FERTILITY TESTING DEVICES MARKET RESEARCH AND ANALYSIS BY REGULATORY CLASSIFICATION, 2020-2027 ($ MILLION)
• 18. EUROPEAN FERTILITY TESTING DEVICES MARKET RESEARCH AND ANALYSIS BY END USER, 2020-2027 ($ MILLION)
• 19. ASIA-PACIFIC FERTILITY TESTING DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
• 20. ASIA-PACIFIC FERTILITY TESTING DEVICES MARKET RESEARCH AND ANALYSIS BY TYPE,2020-2027 ($ MILLION)
• 21. ASIA-PACIFIC FERTILITY TESTING DEVICES MARKET RESEARCH AND ANALYSIS BY REGULATORY CLASSIFICATION, 2020-2027 ($ MILLION)
• 22. ASIA-PACIFIC FERTILITY TESTING DEVICES MARKET RESEARCH AND ANALYSIS BY END USER, 2020-2027 ($ MILLION)
• 23. REST OF THE WORLD FERTILITY TESTING DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
• 24. REST OF THE WORLD FERTILITY TESTING DEVICES MARKET RESEARCH AND ANALYSIS BY TYPE,2020-2027 ($ MILLION)
• 25. REST OF THE WORLD FERTILITY TESTING DEVICES MARKET RESEARCH AND ANALYSIS BY REGULATORY CLASSIFICATION, 2020-2027 ($ MILLION)
• 26. REST OF THE WORLD FERTILITY TESTING DEVICES MARKET RESEARCH AND ANALYSIS BY END USER, 2020-2027 ($ MILLION)

LIST OF FIGURES

• 1. GLOBAL FERTILITY TESTING DEVICES MARKET SHARE BY TYPE,2020 VS 2027 (%)
• 2. GLOBAL FERTILITY TESTING DEVICES MARKET SHARE BY REGULATORY CLASSIFICATION, 2020 VS 2027 (%)
• 3. GLOBAL FERTILITY TESTING DEVICES MARKET SHARE BY END USER, 2020 VS 2027 (%)
• 4. GLOBAL FERTILITY TESTING DEVICES MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
• 5. GLOBAL FEMALE FERTILITY TESTING MARKET SHARE BY REGION, 2020 VS 2027 (%)
• 6. GLOBAL MALE FERTILITY TESTING MARKET SHARE BY REGION, 2020 VS 2027 (%)
• 7. GLOBAL OVER THE COUNTER (OTC)MARKET SHARE BY REGION, 2020 VS 2027 (%)
• 8. GLOBAL PRESCRIPTION (RX)MARKET SHARE BY REGION, 2020 VS 2027 (%)
• 9. GLOBAL HOSPITALS AND FERTILITY CLINICS MARKET SHARE BY REGION, 2020 VS 2027 (%)
• 10. GLOBAL HOME CARE SETTING MARKET SHARE BY REGION, 2020 VS 2027 (%)
• 11. US FERTILITY TESTING DEVICES MARKET SIZE, 2020-2027($ MILLION)
• 12. CANADA FERTILITY TESTING DEVICES MARKET SIZE, 2020-2027($ MILLION)
• 13. UK FERTILITY TESTING DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
• 14. FRANCE FERTILITY TESTING DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
• 15. GERMANY FERTILITY TESTING DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
• 16. ITALY FERTILITY TESTING DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
• 17. SPAIN FERTILITY TESTING DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
• 18. REST OF EUROPE FERTILITY TESTING DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
• 19. INDIA FERTILITY TESTING DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
• 20. CHINA FERTILITY TESTING DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
• 21. JAPAN FERTILITY TESTING DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
• 22. SOUTH KOREA FERTILITY TESTING DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
• 23. REST OF ASIA-PACIFIC FERTILITY TESTING DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
• 24. REST OF THE WORLD FERTILITY TESTING DEVICES MARKET SIZE, 2020-2027 ($ MILLION)

Global Fertility Testing Devices Market Size, Share & Trends Analysis Report by Type (Female Fertility Testing, and Male Fertility Testing), By Regulatory Classification (Over the Counter (OTC), and Prescription (Rx)), By End-User (Hospitals and Fertility Clinics, and Home Care Setting) Forecast Period 2021-2027

The global fertility testing devices market is anticipated to grow at a significant CAGR of 5.9% during the forecast period. Fertility testing devices are electronic devices that are used to monitor and analyze the changes in hormone levels in urine, body temperature, saliva, and other samples to predict or detect the fertility of the user. The decreasing fertility rate in females and the availability of such devices and kits on online websites and portal is the major driving factor for the market. The growing technological advancements, rise in prevalence of obesity, and the rising median age of first-time pregnancies in women are also the factors that are driving the market growth during the forecast period. Additionally, the adoption of the point of care devices and the increasing prevalence of ovarian diseases are the key attributing factor for fueling the growth of the fertility testing devices market.

Furthermore, increasing acceptance of basal body temperature-based ovulation monitors, and the rising acceptance rate of fertility devices are the factors that are propelling the growth of the market. Additionally, the increasing use of mobile applications and websites for ovulation tracking is the major restraining factor for the market. Besides, the cost of ovulation monitoring devices is high, and the Lack of predictive power to confirm ovulation is further hampering the growth of the market. However, pharma healthcare firms are investing in the manufacturing of fertility testing devices that will turn out to be a significant opportunity to the market.

Segmental Outlook

The global fertility testing devices market is segmented based on type, regulatory classification, and end-user. Based on the type, the market is bifurcated into female fertility testing and male fertility testing. The ovulation testing device segment is anticipated to hold a significant share in the global market due to easily availability in the market, faster results, and ease of use. Based on the regulatory classification, the market is segmented into over the counter (OTC), and prescription (Rx). Apart from it, based on the end-user, the market is segmented into hospitals and fertility clinics, and home care settings.

Global Fertility Testing Devices Market Share by Type, 2020 (%)

Global Fertility Testing Devices Market Share by Type

Female fertility segment holds the significant share in the global female infertility testing devices market

The female fertility segment held a dominant share in the end-use segment in 2020 and is anticipated to attain considerable growth during the forecast period. The market is growning mainly due to rising application of ovulation testing device owing to its ready availability, low cost and high efficiency. Ovulation testing kits are used to detect the exact day of ovulation for a woman. There are various kinds of ovulation prediction kits in the market. The kits are usually antibody tests for luteinizing hormone (LH) in the urine. LH levels rise 24-36 hours before ovulation. The high level of LH indicates that the release of the egg (ovulation) usually occurs 12-24 hours after the test turns positive.

Regional Outlooks

The global fertility testing devices market is further segmented based on geography including North America, Europe, Asia-Pacific, and the Rest of the World. North America holds the significant share in the fertility testing device market. It is growing due to the prevalence of polycystic ovarian disease and consumption of alcohol and smoke products. Additionally, the stringent regulatory policy and the approval of the medical devices in the region are also growing the market in the region. Besides, the rise in obesity and the increase in awareness of the people toward fertility testing is also fueling the growth of the market in the region. The prevalence of infertility in the region is also boosting the market in the region.

Global Fertility Testing Devices Market Growth, by Region 2021-2027

Global Fertility Testing Devices Market Growth, by Region

Asia-Pacific is anticipated to have considerable share in the global fertility testing devices market

Asia-Pacific is anticipated to grow at a significant pace in the global fertility testing devices market during the forecast period. The factors such as increasing infertility cases due to the change in lifestyle are anticipating the growth of this market in the Asia Pacific. The rise in prevalence of lifestyle-related disease, and the increase in population in the countries such as China, Japan, and India are offering a significant opportunity for the market in the region. The increasing attention of the major domestic and international players and increasing expenditure for the establishment of ovulation & fertility monitors is increasing the demand for the fertility testing devices market in the Asia-Pacific..

Market Players Outlook

The key players of the fertility testing devices market includes Church & Dwight Co, Inc., Swiss Precision Diagnostics GmbH, Fairhaven Health, LLC, bioZhena Corporation, Geratherm Medical AG, Hilin Life Products, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, and new product launches, to stay competitive in the market. For instance, in June 2020, Modern Fertility launched pregnancy kits and ovulation test kits, along with a mobile app to centralize all fertility-related data, which include understanding the unique cycle and ovulation patterns.

The Report Covers

Market value data analysis of 2020 and forecast to 2027.

Annualized market revenues ($ million) for each market segment.

Country-wise analysis of major geographical regions.

Key companies operating in the global fertility testing devices market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.

Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.

Analysis of market-entry and market expansion strategies.

Competitive strategies by identifying 'who-stands-where' in the market

Table of Contents

1. Report Summary

• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. BY Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
  • 3.1.1. Overview
  • 3.1.2. Financial Analysis
  • 3.1.3. SWOT Analysis
  • 3.1.4. Recent Developments
• 3.2. Key Strategy Analysis

4. Market Determinants

• 4.1. Motivators
• 4.2. Restraints
• 4.3. Opportunities

5. Market Segmentation

• 5.1. Global Fertility Testing Devices Market byType
  • 5.1.1. Female Fertility Testing
    • 5.1.1.1. Ovulation Testing Device
    • 5.1.1.2. Testing Device
  • 5.1.2. Male Fertility Testing
• 5.2. Global Fertility Testing Devices Market by Regulatory Classification
  • 5.2.1. Over the Counter (OTC)
  • 5.2.2. Prescription (Rx)
• 5.3. Global Fertility Testing Devices Market by End-User
  • 5.3.1. Hospitals and Fertility Clinics
  • 5.3.2. Home Care Setting

6. Regional Analysis

• 6.1. North America
  • 6.1.1. United States
  • 6.1.2. Canada
• 6.2. Europe
  • 6.2.1. UK
  • 6.2.2. Germany
  • 6.2.3. Italy
  • 6.2.4. Spain
  • 6.2.5. France
  • 6.2.6. Rest of Europe
• 6.3. Asia-Pacific
  • 6.3.1. China
  • 6.3.2. India
  • 6.3.3. Japan
  • 6.3.4. South Korea
  • 6.3.5. Rest of Asia-Pacific
• 6.4. Rest of the World

7. Company Profiles

• 7.1. Abbott Laboratories, Inc.
• 7.2. Alfa Scientific Designs, Inc.
• 7.3. Ava Science Inc.
• 7.4. Babystart Ltd.
• 7.5. bioMerieux S.A
• 7.6. bioZhena Corp.
• 7.7. Church & Dwight Co, Inc.
• 7.8. Cook Medical Inc.
• 7.9. Eli Lilly And Co.
• 7.10. Fairhaven Health, LLC
• 7.11. Fertility Focus Ltd.
• 7.12. Gemc Technology Group Ltd.
• 7.13. Geratherm Medical AG
• 7.14. GlaxoSmithKline plc
• 7.15. Hilin Life Products, Inc.
• 7.16. Janssen Global Services, LLC
• 7.17. Merck KGaA
• 7.18. Novartis International AG
• 7.19. Pfizer Inc.
• 7.20. SPD Swiss Precision Diagnostics GmbH
• 7.21. TaiDoc Technology Corp